Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Malignant hyperthermia susceptibility in patients with Duchenne’s muscular dystrophy

  • 208 Accesses

  • 8 Citations

References

  1. 1

    Richard WC. Anaesthesia and serum phosphokinase levels in patients with Duchenne’s pseudohypertrophic dystrophy. Anaesth Intensive Care 1972; 1: 150–3.

  2. 2

    Kelfer HM, Singer WD, Reynolds RN. Malignant hyperthermia in a child with Duchenne muscular dystrophy. Pediatrics 1983; 71: 118–9.

  3. 3

    Brownell AKW, Paasuke RT, Elash A, et al. Malignant hyperthermia in Duchenne muscular dystrophy. Anesthesiology 1983; 2: 180–2.

  4. 4

    Sethna NF, Rockoff MA, Worthen MH, et al. Anesthesiarelated complications in children with Duchenne muscular dystrophy. Neurology 1986; 36 (suppl. 1): 152.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Peluso, A., Bianchini, A. Malignant hyperthermia susceptibility in patients with Duchenne’s muscular dystrophy. Can J Anaesth 39, 1117–1118 (1992). https://doi.org/10.1007/BF03008386

Download citation

Keywords

  • Spinal Cord Injury
  • Duchenne Muscular Dystrophy
  • Malignant Hyperthermia
  • Malignant Hyperthermia
  • Peripheral Nerve Stimulator